Hemangioendothelioma with a Prominent Lymphoid Infiltrate Mimicking Follicular Dendritic Cell Tumor: Report of a Case

• Justin Kerstetter

  Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA

• Mia Perez

  Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA

• Craig Zuppan

  Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA

• Paul Herrmann

  Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA

• John R. Goldblum

  Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA

• Jun Wang

  Department of Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, California, USA

 Hemangioendothelioma is a vascular tumor with several different morphologic patterns that can include a component of ovoid or spindled cells, but generally lacks an inflammatory component. The combined morphologic and immunohistochemical features are generally sufficient to accurately diagnose this tumor and its many variants. We present a challenging lymphocyte-rich soft tissue lesion that was not recognized to be an unusual hemangioendothelioma until after several recurrences in the arm of a 63 year-old male, which was originally diagnosed as a follicular dendritic cell tumor instead. Local recurrence developed 3 and 11 years later with resections. The most recent tumor consisted predominantly of epithelioid spindled cells with moderate amounts of bubbly pale to eosinophilic cytoplasm with rare discrete cytoplasmic vacuoles, admixed with a prominent lymphoid infiltrate and occasional erythrocytes. The tumor cells were positive for keratin and vascular markers (CD31, CD34, and Factor VIII), but negative for follicular dendritic cell markers (CD21, CD23, CD35). Slides from the two previous excisions were re-analyzed, and showed the same morphologic and immunohistochemical features as the latest recurrence. The diagnosis was revised to recurrent lymphocyte-rich hemangioendothelioma. The patient is free of tumor at 7 years follow-up. This represents an unusual and potentially confusing pattern of hemangioendothelioma that is not previously well described in the literature. Vascular tumors should be included in the differential diagnosis of suspected dendritic cell tumors, even if a lymphocyte-rich infiltrate is present. Vascular as well as dendritic cell markers should be included in the immunohistochemical panel employed in their evaluation.

Chan JKC. Proliferative Lesions of Follicular Dendritic Cells: An Overview, Including a Detailed Account of Follicular Dendritic Cell Sarcoma, of a Neoplasm with Many Faces and Uncommon Etiologic Associations. Adv Anatomic Pathol 1997; 4: 387-11. http://dx.doi.org/10.1097/00125480-199711000-00048

Biddle DA, Ro JY, Yoon GS, Yong YWH, Ayala G, Ordonez G. Extranodal Follicular Dendritic Cell Sarcoma of the Head and Neck Region: Three Cases, with a Review of the Literature. Mod Pathol 2002; 15: 50-8. http://dx.doi.org/10.1038/modpathol.3880489

Youen KE, Waugh MS. Extranodal Follicular Dendritic Cell Sarcoma. Arch Pathol Lab Med 2008; 132: 1683-7.

Weiss SW, Bridge JA. Epithelioid hemangioendothelioma. In: Fletcher CDM, et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press 2002; p. 173-4.

Chan JKC, Fletcher CDM, Nayler SJ, Cooper K. Follicular Dendritic Cell Sarcoma: Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997; 79: 294-13. http://dx.doi.org/10.1002/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W

Chan, JKC. Tumors of histiocytes and dendritic cells: Follicular Dendritic Cell Sarcoma. In: Fletcher CDM, et al. Eds. Diagnostic Histopathology of Tumors, 3rd ed. Philadelphia: Churchill Livingston 2007; pp. 1240-2.

Weiss SM, Enzinger FM. Epithelioid Hemangioendothelioma: A distinctive vascular tumor often mistaken for carcinoma. Cancer 1982; 50: 970-81. http://dx.doi.org/10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z

Calonje ED, Fletcher CDM. Malignant vascular tumors: Epithelioid Hemangioendothelioma. In: Fletcher CDM, et al. Eds. Diagnostic Histopathology of Tumors, 3rd ed. Philadelphia: Churchill Livingston 2007; pp. 62-63.

Weiss SW, Goldblum JR, Eds. Enzinger and Weiss’ SW Soft Tissue Tumors, 5th ed. St. Louis: Mosby 2008.

Kleer CG, Krishnan UK, McLeod RA. Epithelioid Hemangioendothelioma of Bone. Am J Surg Pathol 1996; 20: 1301-11. http://dx.doi.org/10.1097/00000478-199611000-00001

Ignacio EA, Palmer KM. Epithelioid Hemangioendothelioma of the Lower Extremity. Radiographics 1999; 19: 531-37.

Beaubien ER, Ball NJ, Storwick GS. Kaposiform hemangioendothelioma: a locally aggressive vascular tumor. J Am Acad Dermatol 1998; 38(5 Pt 2): 799-802. http://dx.doi.org/10.1016/S0190-9622(98)70461-X

Rubin BP. Composite hemangioendothelioma. In: Fletcher CDM, et al. editors. WHO Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press 2002; p. 168-9.

Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe SL, Weiss SW. Kaposiform Hemangioendothelioma: A Study of 33 Cases Emphasizing its Pathologic, Immunophenotypic, and Biologic Uniqueness from Juvenile Hemangioma. Am J Surg Pathol 2004; 28: 559-68. http://dx.doi.org/10.1097/00000478-200405000-00001

Fetsch JF. Epithelioid hemangioma. In: Fletcher CDM, et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press 2002; pp. 159-60.

• PDF